CA2289283A1 - Metastasis models using green fluorescent protein (gfp) as a marker - Google Patents

Metastasis models using green fluorescent protein (gfp) as a marker Download PDF

Info

Publication number
CA2289283A1
CA2289283A1 CA002289283A CA2289283A CA2289283A1 CA 2289283 A1 CA2289283 A1 CA 2289283A1 CA 002289283 A CA002289283 A CA 002289283A CA 2289283 A CA2289283 A CA 2289283A CA 2289283 A1 CA2289283 A1 CA 2289283A1
Authority
CA
Canada
Prior art keywords
gfp
tumor
contain
metastasis
tumors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002289283A
Other languages
French (fr)
Other versions
CA2289283C (en
Inventor
Yuying Tan
Takashi Chishima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anticancer Inc
Original Assignee
Anticancer, Inc.
Yuying Tan
Takashi Chishima
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26727289&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2289283(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/848,539 external-priority patent/US6232523B1/en
Application filed by Anticancer, Inc., Yuying Tan, Takashi Chishima filed Critical Anticancer, Inc.
Publication of CA2289283A1 publication Critical patent/CA2289283A1/en
Application granted granted Critical
Publication of CA2289283C publication Critical patent/CA2289283C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0045—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent agent being a peptide or protein used for imaging or diagnosis in vivo
    • A61K49/0047—Green fluorescent protein [GFP]
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New breeds of animals
    • A01K67/027—New breeds of vertebrates
    • A01K67/0271—Chimeric animals, e.g. comprising exogenous cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43595—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from coelenteratae, e.g. medusae
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Abstract

A method to follow the progression of metastasis of a primary tumor, which method comprises removing fresh organ tissues from a vertebrate subject which has been modified to contain tumor cells that express GFP and observing the excised tissues for the presence of fluorescence is disclosed. The fluorescence can also be monitored by observing the tissues in situ. Vertebrate subjects which contain GFP
producing tumors are useful models to study the mechanism of metastasis.
In addition, subjects already harboring tumors can be treated so as to modify the endogenous tumors to contain GFP. This permits clinical applications. Finally, by injecting a contrast dye into a subject harboring a GFP-labeled tumor, angiogenesis in the tumor can be observed directly.
CA002289283A 1997-04-28 1998-04-28 Metastasis models using green fluorescent protein (gfp) as a marker Expired - Fee Related CA2289283C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US08/848,539 US6232523B1 (en) 1997-04-28 1997-04-28 Metastasis models using green fluorescent protein (GFP) as a marker
US08/848,539 1997-04-28
US09/049,544 1998-03-27
US09/049,544 US6235967B1 (en) 1997-04-28 1998-03-27 Metastasis models using green fluorescent protein as a marker
PCT/US1998/008457 WO1998049336A1 (en) 1997-04-28 1998-04-28 Metastasis models using green fluorescent protein (gfp) as a marker

Publications (2)

Publication Number Publication Date
CA2289283A1 true CA2289283A1 (en) 1998-11-05
CA2289283C CA2289283C (en) 2009-08-11

Family

ID=26727289

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002289283A Expired - Fee Related CA2289283C (en) 1997-04-28 1998-04-28 Metastasis models using green fluorescent protein (gfp) as a marker

Country Status (8)

Country Link
US (1) US6235968B1 (en)
EP (1) EP0979298B1 (en)
JP (2) JP2001517090A (en)
CN (1) CN1264429A (en)
AU (1) AU749338B2 (en)
CA (1) CA2289283C (en)
DE (1) DE69839603D1 (en)
WO (1) WO1998049336A1 (en)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6235968B1 (en) 1997-04-28 2001-05-22 Anticancer, Inc. Metastasis models using green fluorescent protein (GFP) as a marker
US6251384B1 (en) 1997-04-28 2001-06-26 Anticancer, Inc. Metastasis models using green fluorescent protein (GFP) as a marker
US6232523B1 (en) 1997-04-28 2001-05-15 Anticancer, Inc. Metastasis models using green fluorescent protein (GFP) as a marker
FR2796393B1 (en) * 1999-07-15 2003-10-31 Inst Nat Sante Rech Med MODEL FOR STUDYING THE PROGRESSION OF SPONTANEOUS PULMONARY METASTASES, AND ITS USE IN THE SCREENING OF DRUGS
EP1294906B1 (en) 2000-03-17 2009-01-21 Anticancer, Inc. Whole-body optical imaging of gene expression and uses thereof
AU2002251830A1 (en) * 2001-01-26 2002-08-06 Colorado State University Research Foundation Analysis of gene expression and biological function using optical imaging
US20020132318A1 (en) * 2001-01-29 2002-09-19 Ming Zhao Fluorescent proteins
JP2005520781A (en) * 2001-07-09 2005-07-14 アンチキャンサー インコーポレーテッド Imaging infection using fluorescent proteins as markers
EP1281767A3 (en) * 2001-07-31 2003-05-28 Aladar A. Szalay Light emitting microorganisms and cells for diagnosis and therapy of tumors
AU2002326872B2 (en) * 2001-09-10 2008-07-03 Anticancer, Inc. Enhanced resolution of tumor metastasis
US7280680B2 (en) 2002-03-04 2007-10-09 Riken Method and apparatus for observing three-dimensional localizations of in vivo expressed genes as well as method and apparatus for observing minute three-dimensional localizations of in vivo expressed genes
US20030228261A1 (en) * 2002-06-05 2003-12-11 Aladar Szalay Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue
EP1369491A1 (en) * 2002-06-05 2003-12-10 Aladar A. Szalay Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue
CA2495411C (en) * 2002-08-16 2013-12-10 Anticancer, Inc. Real time measurement of cellular responses
WO2004106497A2 (en) * 2003-05-27 2004-12-09 Anticancer, Inc. Imageable animal model of sars infection
EP1631935A4 (en) * 2003-06-09 2008-10-15 Univ Singapore System and method for providing a service
AU2004289953B2 (en) 2003-06-18 2008-09-25 Genelux Corporation Modified recombinant vaccina viruses and other microorganisms, uses thereof
CN1295340C (en) * 2003-08-13 2007-01-17 上海南方模式生物科技发展有限公司 Method for extablishing polymorphism adenoid tumour mouse model
US8634607B2 (en) 2003-09-23 2014-01-21 Cambridge Research & Instrumentation, Inc. Spectral imaging of biological samples
US7321791B2 (en) 2003-09-23 2008-01-22 Cambridge Research And Instrumentation, Inc. Spectral imaging of deep tissue
US7155274B1 (en) 2003-11-21 2006-12-26 Imaging Diagnostic Systems, Inc. Optical computed tomography scanner for small laboratory animals
CN101151623B (en) 2005-01-27 2010-06-23 剑桥研究和仪器设备股份有限公司 Method and equipment for classifying sample image features
EP1954809B1 (en) * 2005-09-30 2011-08-03 AntiCancer, Inc. Methods for indentifying markers for early-stage human cancer, cancer progression and recurrence
KR100912784B1 (en) 2006-01-05 2009-08-18 엘지전자 주식회사 Data transmission method and data retransmission method
US8493854B2 (en) 2006-02-07 2013-07-23 Lg Electronics Inc. Method for avoiding collision using identifier in mobile network
EP2037270A3 (en) * 2006-03-31 2009-03-25 F. Hoffmann-La Roche Ag Tumor models employing green fluorescent protein
KR20070121505A (en) 2006-06-21 2007-12-27 엘지전자 주식회사 Method for reconfiguring radio link
TW200819540A (en) 2006-07-11 2008-05-01 Genelux Corp Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders
EP2415783B1 (en) 2006-10-16 2016-12-14 Genelux Corporation Modified vaccinia virus strains for use in a diagnostic and therapeutic method
CA2690627C (en) * 2007-06-15 2014-12-02 Genelux Corporation Microorganisms for imaging and/or treatment of tumors
CA2700543A1 (en) * 2007-10-01 2009-04-09 Anticancer, Inc. Imageable rodent model of asthma
WO2012142529A2 (en) 2011-04-15 2012-10-18 Genelux Corporation Clonal strains of attenuated vaccinia viruses and methods of use thereof
RU2562878C1 (en) * 2014-07-01 2015-09-10 Михаил Юрьевич Бяхов Method for simulating serrated colon adenoma
CA3102210C (en) 2015-11-02 2022-06-14 Pura Scents, Inc. Scent dispensation
USD809116S1 (en) 2015-11-02 2018-01-30 Pura Scents Dispenser
USD816506S1 (en) 2015-11-02 2018-05-01 Pura Scents, Inc. Vial for a scent dispenser
CN107361024A (en) * 2017-07-18 2017-11-21 郑州大学 A kind of method for building up of esophageal squamous cell carcinoma early stage metastasis model
CN108795872B (en) * 2018-06-05 2022-05-27 南方医科大学 In-vitro tumor cell 3D collective invasion model and construction method thereof
CN110157684A (en) * 2019-05-30 2019-08-23 浙江省肿瘤医院 RFP marks small cell lung cancer cell system and its foundation and application

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5650135A (en) 1994-07-01 1997-07-22 The Board Of Trustees Of The Leland Stanford Junior University Non-invasive localization of a light-emitting conjugate in a mammal
WO1997045550A2 (en) 1996-05-31 1997-12-04 Baxter International Inc. Mini-adenoviral vector
US6235968B1 (en) 1997-04-28 2001-05-22 Anticancer, Inc. Metastasis models using green fluorescent protein (GFP) as a marker

Also Published As

Publication number Publication date
AU7164898A (en) 1998-11-24
JP2005006660A (en) 2005-01-13
EP0979298A1 (en) 2000-02-16
JP2001517090A (en) 2001-10-02
WO1998049336A1 (en) 1998-11-05
DE69839603D1 (en) 2008-07-24
CA2289283C (en) 2009-08-11
US6235968B1 (en) 2001-05-22
CN1264429A (en) 2000-08-23
AU749338B2 (en) 2002-06-27
EP0979298B1 (en) 2008-06-11

Similar Documents

Publication Publication Date Title
CA2289283A1 (en) Metastasis models using green fluorescent protein (gfp) as a marker
ATE391515T1 (en) METASTASIS MODELS USING GREEN FLUORESCENT PROTEIN (GFP) AS A MARKER
ATE398183T1 (en) METASTASIS MODELS USING GREEN FLUORESCENT PROTEIN
Jaque et al. Inorganic nanoparticles for optical bioimaging
DE69916581D1 (en) A UNIVERSAL IMMUNO-MODULATORY CYTOKIN-EXPRESSING CELL LINE IN WAITING. CORRESPONDING COMPOSITIONS AND METHODS OF THEIR PRODUCTION AND USE
Bhuta et al. Myxoid malignant melanoma: a previously undescribed histologic pattern noted in metastatic lesions and a report of four cases
ES2179196T3 (en) TERNARY RADIOPHARMACIC COMPLEXES.
ATE295416T1 (en) HUMANIZED GREEN FLUORESCENCE PROTEIN AND METHODS
ATE206124T1 (en) DETECTFULLY LABELED MARKER COMPOUND WITH A FLUOROPHORE RESIDUE, A FLUORESCENCE SAMPLE WITH THE MARKER COMPOUND AND USES THEREOF.
DE69934694D1 (en) BPC-1: A DISEASED BRAIN SPECIFIC PROTEIN EXPRESSED AND EMBROIDERED BY PROSTATE AND BLADDER CANCER CELLS
Hardie et al. A new method for imaging and 3D reconstruction of mammalian cochlea by fluorescent confocal microscopy
Brehm et al. Localization and characterization of luminescent cells in Ophiopsila californica and Amphipholis squamata (Echinodermata: Ophiuroidea)
Beams et al. Light and electron microscope studies on the light organ of the firefly (Photinus pyralis)
WO2002055735A3 (en) Compositions and methods relating to prostate specific genes and proteins
Pääkkö et al. Immunohistochemical evidence that lung carcinomas grow on alveolar basement membranes
DE69424209D1 (en) Tumor suppressor gene Merlin and its uses
DE60038630D1 (en) METHOD FOR THE EX VIVO FORMATION OF MAMMALIAN BONE AND ITS USES
IT1309715B1 (en) METHOD AND EQUIPMENT FOR THE CREATION OF MUSICAL ACCOMPANIMENTS BY METAMORPHOSIS OF STYLES
WO2002077232A3 (en) Compositions and methods relating to breast specific genes and proteins
Lukacs et al. Epithelial stem cells of the prostate and their role in cancer progression
WO2002040673A3 (en) Compositions and methods relating to lung specific genes and proteins
Esponda Cytochemistry of kinetochores under electron microscopy
NO991317D0 (en) Preparation for immunohistochemical staining
NO994622L (en) Use of proteins that can be extracted from animal organs for the manufacture of drugs for the treatment of pathological conditions that are distinctive by tumor production of tumor necrosis factor (TNF)
JP2013124924A (en) Dyeing kit and dyeing method

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20180430